JAK2 and acquired polycythemia vera: The patient exhibited an unprecedented 80% allele frequency of JAK2 V617F, significantly exceeding the average 30 to 50% observed in typical polycythemia vera cases, which led to abnormal enhancement of thrombopoietin signaling and megakaryocyte proliferation.